Treatment with long-acting risperidone injection is not associated with reductions in hospital stay or resource use

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.513, 2006-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Risperidone Long-Acting Injection in the Treatment of First Episode Schizophrenia

By Rocca P. Sandei L. M. Bava I. Frieri T.

Current Psychopharmacology, Vol. 2, Iss. 1, 2013-02 ,pp. : 29-36

Bentham Science Publishers

Access to resources Recommend Favorite

Risperidone Long-Acting Injection in the Treatment of First Episode Schizophrenia

Current Psychopharmacology, Vol. 2, Iss. 1, 2013-02 ,pp. : 29-36

Bentham Science Publishers

Access to resources Recommend Favorite

Risperidone Long-Acting Injection: In Bipolar I Disorder

By Deeks Emma D.

Drugs, Vol. 70, Iss. 8, 2010-05 ,pp. : 1001-1012

Adis International

Access to resources Recommend Favorite

Olanzapine Long-Acting Injection: A Review of its Use in the Treatment of Schizophrenia

By Frampton James E.

Drugs, Vol. 70, Iss. 17, 2010-12 ,pp. : 2289-2313

Adis International

Access to resources Recommend Favorite

Long-Acting Risperidone: A Review of Its Use in Schizophrenia

By Tracy Swainston Harrison Goa K.L.

CNS Drugs, Vol. 18, Iss. 2, 2004-01 ,pp. : 113-132

Adis International

Access to resources Recommend Favorite